ClinicalTrials.govpublic full text
Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol
alzheimer disease, mild cognitive impairment, dementia, healthy volunteers, amyloid, pet, ultralow dose, pet/ct, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 910424
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.